[go: up one dir, main page]

DK0878195T3 - Anvendelse af en 2-aroyl-3-arylbenzo(b)thiophenforbindelse til reduktion af fibrinogenniveauerne - Google Patents

Anvendelse af en 2-aroyl-3-arylbenzo(b)thiophenforbindelse til reduktion af fibrinogenniveauerne

Info

Publication number
DK0878195T3
DK0878195T3 DK98303055T DK98303055T DK0878195T3 DK 0878195 T3 DK0878195 T3 DK 0878195T3 DK 98303055 T DK98303055 T DK 98303055T DK 98303055 T DK98303055 T DK 98303055T DK 0878195 T3 DK0878195 T3 DK 0878195T3
Authority
DK
Denmark
Prior art keywords
aroyl
arylbenzo
thiophene compound
fibrinogen levels
reduce fibrinogen
Prior art date
Application number
DK98303055T
Other languages
English (en)
Inventor
Pamela Wang Anderson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0878195T3 publication Critical patent/DK0878195T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98303055T 1997-04-22 1998-04-21 Anvendelse af en 2-aroyl-3-arylbenzo(b)thiophenforbindelse til reduktion af fibrinogenniveauerne DK0878195T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4459197P 1997-04-22 1997-04-22

Publications (1)

Publication Number Publication Date
DK0878195T3 true DK0878195T3 (da) 2002-07-15

Family

ID=21933208

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98303055T DK0878195T3 (da) 1997-04-22 1998-04-21 Anvendelse af en 2-aroyl-3-arylbenzo(b)thiophenforbindelse til reduktion af fibrinogenniveauerne

Country Status (23)

Country Link
US (1) US6025373A (da)
EP (1) EP0878195B1 (da)
JP (1) JP2001524101A (da)
KR (1) KR20010012084A (da)
CN (1) CN1254255A (da)
AT (1) ATE219364T1 (da)
AU (1) AU741720B2 (da)
BR (1) BR9809286A (da)
CA (1) CA2287196A1 (da)
DE (1) DE69806098T2 (da)
DK (1) DK0878195T3 (da)
EA (1) EA002237B1 (da)
ES (1) ES2178111T3 (da)
HU (1) HUP0002727A3 (da)
ID (1) ID22910A (da)
IL (1) IL132504A0 (da)
NO (1) NO995132D0 (da)
NZ (1) NZ500389A (da)
PL (1) PL336638A1 (da)
PT (1) PT878195E (da)
TR (1) TR199902605T2 (da)
WO (1) WO1998047365A1 (da)
ZA (1) ZA983298B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103740A (en) * 1997-08-21 2000-08-15 Eli Lilly And Company Methods for lowering platelet counts
FR2777784B1 (fr) * 1998-04-27 2004-03-19 Arepa Composition pharmaceutique a base d'estrogene et de progesterone
US6353003B1 (en) 1998-06-17 2002-03-05 Eli Lilly And Company Method for reducing levels of homocysteine and C-reactive protein

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
EP0612500B1 (en) * 1991-12-17 1998-10-28 DYNAMICS IMAGING, Inc. Method and device for diagnosis of living organism
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US5445941A (en) * 1993-06-21 1995-08-29 Eli Lilly And Company Method for screening anti-osteoporosis agents
JPH07149638A (ja) * 1993-10-15 1995-06-13 Eli Lilly & Co 耐性新生物の治療法
US5476862A (en) * 1993-12-21 1995-12-19 Eli Lilly And Company Methods of increasing thrombomodulin expression
US5441965A (en) * 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting thrombin
FI973235L (fi) * 1995-02-06 1997-08-05 Lilly Co Eli Menetelmä IL-6:n vaikutusten inhiboimiseksi
US5731328A (en) * 1995-10-10 1998-03-24 Eli Lilly And Company Methods of inhibiting plasminogen activator inhibitor 1

Also Published As

Publication number Publication date
EA002237B1 (ru) 2002-02-28
PT878195E (pt) 2002-09-30
CA2287196A1 (en) 1998-10-29
HUP0002727A3 (en) 2001-09-28
ATE219364T1 (de) 2002-07-15
US6025373A (en) 2000-02-15
ID22910A (id) 1999-12-16
WO1998047365A1 (en) 1998-10-29
HUP0002727A2 (hu) 2001-08-28
ES2178111T3 (es) 2002-12-16
CN1254255A (zh) 2000-05-24
DE69806098T2 (de) 2003-01-02
AU741720B2 (en) 2001-12-06
AU7250398A (en) 1998-11-13
KR20010012084A (ko) 2001-02-15
NZ500389A (en) 2001-07-27
EA199900959A1 (ru) 2000-06-26
JP2001524101A (ja) 2001-11-27
IL132504A0 (en) 2001-03-19
DE69806098D1 (de) 2002-07-25
BR9809286A (pt) 2000-07-04
NO995132L (no) 1999-10-21
ZA983298B (en) 1999-10-20
MX9909548A (es) 2003-02-27
TR199902605T2 (xx) 2000-02-21
NO995132D0 (no) 1999-10-21
EP0878195B1 (en) 2002-06-19
EP0878195A1 (en) 1998-11-18
PL336638A1 (en) 2000-07-03

Similar Documents

Publication Publication Date Title
CO4230019A1 (es) Antagonistas de neuroquinina diazabiciclica
IT1271014B (it) 3-aril-benzofuranoni come agenti stabilizzanti
TR28718A (tr) Dinamik takilan tipte cocuk bezi.
PT1193270E (pt) Pirrolobenzodiazepinas
FI945557L (fi) Isoksatsoliiniyhdisteet tulehduksenvastaisina aineina
DE69433009D1 (de) Ineinandergreifende gerippte bauelemente
ATE226201T1 (de) Substituierte pyridylpyrazole
HN1998000086A (es) Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
DK0878195T3 (da) Anvendelse af en 2-aroyl-3-arylbenzo(b)thiophenforbindelse til reduktion af fibrinogenniveauerne
LV11463A (lv) Aizvietotu 4,6-diamino-5-cianpirimidinu iegusanas panemiens
BR0114065A (pt) Triazolo-epotilonas
DE59808166D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum
DK0606756T3 (da) Anvendelse af disulfonylmethaner til bekæmpelse af parasitter
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
FI934297L (fi) Fosfolipidderivat, innehaollande grundaemnen ur den femte huvudgruppen med ett hoegt ordingstal
FR2697998B1 (fr) Chevillère.
FR2710673B1 (fr) Composition d'enduit de parement.
KR940000392U (ko) 족관절 속대가 부착된 족복체
YU30198A (sh) Prečišćavanje propilen oksida
DE59307175D1 (de) Korrektur der Starteinspritzzeit
DE69221460D1 (de) Orthopädischer Schuh
DK0909171T3 (da) Anvendelse af L-acetylcarnitin, L-isovalerylcarnitin til at foröge niveauerne af IGF-1
HN1997000019A (es) Nuevas oxazolidinonas sustituidas
ATE149338T1 (de) Beinbewegungsschiene